Divi Pixel Layout Pack
The team is proud to announce the official creation of our start-up, Aceso Therapeutics, which was registered at the Montpellier Registrar's Office on 12 March 2025. Aceso Therapeutics is based on research conducted by PhyMedExp, Inserm, CNRS, and the University of...
Magali Taulan-Cadars (CSO) and Prisca Boisguérin (CTO), along with their academic research team, participated in the 20th ECFS Basic Science Conference in Lido di Camaiore, Italy (https://www.ecfs.eu/bsc2025). Organized by Patrick Harrison (US), Batsheva Kerem (IL)...
From 12th to 14th May 2025, Aceso Therapeutics participated in Bio€quity Europe 2025 in Bruges, Belgium, to showcase our innovative bitherapy for cystic fibrosis — a dual therapy with a unique mechanism to restore CFTR activity. The event was well organised, with an...
From 11–12 November 2025, TIDES Europe in Basel, Switzerland, will bring together industry leaders for a focused and dynamic program. Scientific tracks will cover in-depth discovery, development, and manufacturing strategies, as well as the latest trends and...
Aceso Therapeutics will be attending BIO-Europe 2025 in Vienna, Austria, from 11th to 12th November. This major event will provide a valuable opportunity to share more information about our innovative bitherapy project for cystic fibrosis, which is designed to restore...